|

Super CAR-T Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Guangzhou FineImmune Biotechnology Co., LTD.1

Indications

  • Liver Disease1
  • GPC3 Positive Hepatocellular Carcinoma1
  • Advanced Hepatocellular Carcinoma (HCC)1
  • Liver Cancer1
  • Cancer1

Other1 trial

An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.